Literature DB >> 20936626

Detecting data fabrication in clinical trials from cluster analysis perspective.

Xiaoru Wu1, Martin Carlsson.   

Abstract

Detecting data fabrication is of great importance in clinical trials. As the role of statisticians in detecting abnormal data patterns has grown, a large number of statistical procedures have been developed, most of which are based on descriptive statistics. Based upon the fact that substantial data fabrication cases have certain clustering structures, this paper discusses the potential for the use of statistical clustering method in fraud detection. Three clustering patterns, angular, neighborhood and repeated measurements clustering, are identified and explored. Correspondingly, simple and efficient test statistics are proposed and randomization tests are carried out. The proposed methods are applied to a 12-week multi-center study for illustration. Extensive simulations are conducted to validate the effectiveness of the procedures.
Copyright © 2010 John Wiley & Sons, Ltd.

Mesh:

Year:  2010        PMID: 20936626     DOI: 10.1002/pst.462

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  1 in total

Review 1.  Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: A scoping review.

Authors:  William J Cragg; Caroline Hurley; Victoria Yorke-Edwards; Sally P Stenning
Journal:  Clin Trials       Date:  2021-02-20       Impact factor: 2.486

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.